Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuromodulation for Behavioral Changes in Neurological Disorders

NCT: NCT07718906 · NOT_YET_RECRUITING

NCT IDNCT07718906
StatusNOT_YET_RECRUITING
Start Date2026-07-25
Completion2028-12-30
SponsorWest Virginia University (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to see if a focused ultrasound neuromodulation can be safely and effectively used to treat symptoms of emotional dysregulation such as agitation, irritability and anxiety

Frequently Asked Questions

What is Neuromodulation for Behavioral Changes in Neurological Disorders?

Neuromodulation for Behavioral Changes in Neurological Disorders is a clinical trial registered under NCT07718906. Current status: NOT_YET_RECRUITING.

What is the status of NCT07718906?

The current status of NCT07718906 (Neuromodulation for Behavioral Changes in Neurological Disorders) is: NOT_YET_RECRUITING.

When did Neuromodulation for Behavioral Changes in Neurological Disorders start?

Neuromodulation for Behavioral Changes in Neurological Disorders started on 2026-07-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.